Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial

IMPORTANCE: Medulloblastoma recurrence in patients who have previously received irradiation has a dismal prognosis and lacks a standard salvage regimen. OBJECTIVE: To evaluate the response rate of pediatric patients with medulloblastoma recurrence using an antiangiogenic metronomic combinatorial app...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyrl, Andreas, Chocholous, Monika, Sabel, Magnus, Lassaletta, Alvaro, Sterba, Jaroslav, Leblond, Pierre, Nysom, Karsten, Torsvik, Ingrid, Chi, Susan N., Perwein, Thomas, Jones, Neil, Holm, Stefan, Nyman, Per, Mörse, Helena, Öberg, Anders, Weiler-Wichtl, Liesa, Leiss, Ulrike, Haberler, Christine, Schmook, Maresa T., Mayr, Lisa, Dieckmann, Karin, Kool, Marcel, Gojo, Johannes, Azizi, Amedeo A., André, Nicolas, Kieran, Mark, Slavc, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603581/
https://www.ncbi.nlm.nih.gov/pubmed/37883081
http://dx.doi.org/10.1001/jamaoncol.2023.4437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603581/
https://www.ncbi.nlm.nih.gov/pubmed/37883081
http://dx.doi.org/10.1001/jamaoncol.2023.4437

Ejemplares similares